TL1A

TL1A 詳細

英語名Tumor necrosis factor superfamily member 15市販薬剤の数0
治験薬の数18ターゲットの別称VEGI192A,Vascular Endothelial Cell Growth Inhibitor,TNF Superfamily Ligand TL1A,TNFSF15,Tumor Necrosis Factor (Ligand) Superfamily, Member 15,Vascular Endothelial Growth Inhibitor-192A,VEGI,TL1A,Tumor Necrosis Factor Ligand 1B,TNLG1B,TNF Superfamily Member 15,Tumor Necrosis Factor Superfamily Member 15,TL1,TNF Ligand-Related Molecule 1,Tumor Necrosis Factor Ligand Superfamily Member 15,MGC129934,MGC129935
研究&開発段階Phase 3 Clinical
英語名Tumor necrosis factor superfamily member 15
ターゲットの別称VEGI192A,Vascular Endothelial Cell Growth Inhibitor,TNF Superfamily Ligand TL1A,TNFSF15,Tumor Necrosis Factor (Ligand) Superfamily, Member 15,Vascular Endothelial Growth Inhibitor-192A,VEGI,TL1A,Tumor Necrosis Factor Ligand 1B,TNLG1B,TNF Superfamily Member 15,Tumor Necrosis Factor Superfamily Member 15,TL1,TNF Ligand-Related Molecule 1,Tumor Necrosis Factor Ligand Superfamily Member 15,MGC129934,MGC129935
市販薬剤の数0
治験薬の数18
研究&開発段階Phase 3 Clinical

TL1A 製品リスト

  • 属性

    Protein (13)Cell (5)Kits (2)

  • 製品ライブラリ

    オンライン (19)研究中 (1)

  • Human (12)Cynomolgus / Rhesus macaque (2)Mouse (3)Rat (1)Rabbit (1)Cynomolgus (1)

  • タグ

    His Tag (9)His Tag & Avi Tag (2)- (7)Fc Tag (1)Avi Tag & His Tag (1)

  • マーカー

    Unconjugated (10)Biotin-labeled (3)- (7)

TL1Aバックグランド

TNF-like cytokine 1A (TL1A) and its receptors, death receptor 3 (DR3) and decoy receptor 3 (DcR3) are members of the TNF and TNF receptor superfamilies of proteins, respectively. Binding of APC-derived TL1A to lymphocytic DR3 provides co-stimulatory signals for activated lymphocytes. DR3 signaling affects not only the proliferative activity of and cytokine production by effector lymphocytes, but also critically influences the development and suppressive function of regulatory T-cells. Whereas, DcR3 restricts the function of the TL1A/DR3 complex: attenuating T-cell activation and downregulating the secretion of pro-inflammatory cytokines. Together with DR3 and DcR3, TL1A constitutes a cytokine system that actively interferes with the regulation of immune responses.

TL1A分子の別称

TL1A, VEGI, TNFSF15

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
DuvakitugTEV-48574; TEV-'574; TEV'574; SAR447189; SAR-447189; TEV574; TEV-574Phase 3 ClinicalTeva Pharmaceutical Industries LtdAsthma; Colitis, Ulcerative; Crohn Disease
詳細
TulisokibartPRA-023; MK-7240; PRA023Phase 3 ClinicalMerck Sharp & Dohme LLC, Prometheus Biosciences IncArthritis, Psoriatic; Arthritis, Rheumatoid; Axial Spondyloarthritis; Colitis, Ulcerative; Crohn Disease; Hidradenitis Suppurativa; Inflammatory Bowel Diseases; Lung Diseases, Interstitial; Non-radiographic axial spondyloarthritis; Scleroderma, Diffuse; Spondylitis, Ankylosing
詳細
AfimkibartPF-06480605; PF 6480605; RVT-3101; RG-6631; RO-7790121Phase 3 ClinicalPfizer IncArthritis, Rheumatoid; Colitis, Ulcerative; Crohn Disease; Dermatitis, Atopic; Inflammatory Bowel Diseases; Metabolic Dysfunction-Associated Steatotic Liver Disease
詳細
RO-7837195RO-7837195; RO7837195Phase 2 ClinicalGenentech IncColitis, Ulcerative
詳細
PF-07261271RG-6730; PF-07261271Phase 2 ClinicalPfizer IncInflammatory Bowel Diseases
詳細
SPY0-72SPY002-072; SPY0-72Phase 2 ClinicalSpyre Therapeutics IncArthritis, Psoriatic; Arthritis, Rheumatoid; Axial Spondyloarthritis; Joint Diseases; Rheumatic Diseases
詳細
XmAb-942XmAb942; XmAb-942Phase 2 ClinicalXencor IncColitis, Ulcerative; Inflammatory Bowel Diseases
詳細
BCD-261BCD-261Phase 2 ClinicalBIOCAD JSCColitis, Ulcerative; Crohn Disease; Inflammatory Bowel Diseases
詳細
next-generation anti-TL1A mAb (Pfizer)Phase 1 ClinicalPfizer IncFibrosis; Inflammation
詳細
ENV-6946ENV-6946Phase 1 ClinicalEnveda Biosciences IncInflammatory Bowel Diseases
詳細
QX-030NQX030N; CLD-423; QX-030NPhase 1 ClinicalQyuns Therapeutics Co LtdAutoimmune Diseases; Inflammatory Bowel Diseases
詳細
HXN-1001HXN-1001Phase 1 ClinicalHelixon LtdInflammatory Bowel Diseases; Psoriasis
詳細
GR-2303GR-2303Phase 1 ClinicalChongqing Genrix Biopharmaceutical Co LtdInflammatory Bowel Diseases
詳細
SSGJ-627SSGJ-627; SSGJ627Phase 1 ClinicalSunshine GuoJian Pharmaceutical (Shanghai) Co LtdColitis, Ulcerative
詳細
SPY-002SPY002-091; SPY002 072; SPY-002; PR-010Phase 1 ClinicalParagon Therapeutics Inc
詳細
ABS-101(Absci)ABS-101(Absci); ABS-101Phase 1 ClinicalAbsci CorpInflammatory Bowel Diseases
詳細
FG-M701FG-M-701; ABBV-701; FG-M701Phase 1 ClinicalFutureGen Biopharm (Beijing) Co LtdAutoimmune Diseases
詳細
Next-generation anti-TL1A antibody(Telavant)Phase 1 ClinicalTelavant IncFibrosis; Inflammation
詳細

レビュー

  • 詳細
  • 製品リスト
  • レビュー
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8